| 1NC2 | date | ![]() |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| authors | |||||||||||||||
| compound | source | ||||||||||||||
| symmetry |
| ||||||||||||||
| crystal cell |
| ||||||||||||||
| method | X-Ray Diffraction | resolution | |||||||||||||
| ligand | CL, DOE, NAG, PCA, YT3 | enzyme |
| ||||||||||||
| related structures | by homologous chain: 1IND, 1MFD, 1NDM | ||||||||||||||
| Primary reference | Crystal structures of two complexes of the rare-earth-DOTA-binding antibody 2D12.5: ligand generality from a chiral system., Corneillie TM, Fisher AJ, Meares CF, J Am Chem Soc 2003 Dec 10;125(49):15039-48. PMID:14653738 | ||||||||||||||
| Data retrieval |
![]() |
| View 1NC2 in 3D |
Proteopedia, because life has more than 2D. |
| Structure-derived information |
| Sequence-derived information |
|
OCA© by Jaime Prilusky, 1996-2014,2022,2024 Bioinformatics Unit Weizmann Institute of Science |